Goetz Kathleen — SEC Form 4 filings

SEC reporting owner CIK 1896369. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-04-12 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
abrdn Healthcare Opportunities Fund (THQ)Director11 leg · 600 sh · $11,723
abrdn Healthcare Investors (HQH)Director11 leg · 525 sh · $8,622
abrdn Life Sciences Investors (HQL)Director11 leg · 400 sh · $5,327
abrdn World Healthcare Fund (THW)Director11 leg · 200 sh · $2,506
Aurinia Pharmaceuticals Inc. (AUPH)Director22

Form 4 filings — Goetz Kathleen

FiledFormIssuerReported transactionsSource
2026-06-084Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 23,931 (derivative) @ $0EDGAR
2025-05-164Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 63,724 (derivative) @ $0EDGAR
2024-04-124abrdn Healthcare Opportunities Fund (THQ)Purchase (P): 600 @ $19.54EDGAR
2024-04-124abrdn World Healthcare Fund (THW)Purchase (P): 200 @ $12.53EDGAR
2024-04-124abrdn Healthcare Investors (HQH)Purchase (P): 525 @ $16.42EDGAR
2024-04-124abrdn Life Sciences Investors (HQL)Purchase (P): 400 @ $13.32EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1896369 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →